Bombay HC restrains firm from infringing Sun Pharma trademark Prolomet
The Bombay High Court has noted an ad-interim injunction restraining the Salud Care (India) Private from using trademark PROLOMEK or any other trademark that is identical with or deceptively or confusingly similar to Sun Pharma Laboratories Ltd's mark PROLOMET.The order was issued during a hearing conducted by G S Patel through video conferencing, deliberating the case filed by Sun Pharma....
The Bombay High Court has noted an ad-interim injunction restraining the Salud Care (India) Private from using trademark PROLOMEK or any other trademark that is identical with or deceptively or confusingly similar to Sun Pharma Laboratories Ltd's mark PROLOMET.
The order was issued during a hearing conducted by G S Patel through video conferencing, deliberating the case filed by Sun Pharma. The counsel for Sun Pharma informed the court that in April 2021, Sun Pharma learned that Salud Care (India) Private markets a pharmaceutical preparation for the treatment of hypertension with tachycardia, angina, hyperthyroidism, and myocardial infarction with the same based drug, Metoprolol Succinate, under the trade mark PROLOMEK.
For more details, check out the full story on the link below:
Bombay HC Restrains Firm From Infringing Sun Pharma Trademark Prolomet
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd